Wu, C., Lusvarghi, S., Wang, J., Hsiao, S., Huang, Y., Hung, T., & Ambudkar, S. V. (2019). Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines. Mol Pharm.
Style de citation ChicagoWu, Chung-Pu, Sabrina Lusvarghi, Jyun-Cheng Wang, Sung-Han Hsiao, Yang-Hui Huang, Tai-Ho Hung, et Suresh. V. Ambudkar. "Avapritinib: A Selective Inhibitor of KIT and PDGFRα That Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines." Mol Pharm 2019.
Style de citation MLAWu, Chung-Pu, et al. "Avapritinib: A Selective Inhibitor of KIT and PDGFRα That Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines." Mol Pharm 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.